Pharmacists could prescribe weight-loss jabs for NHS patients as part of a bid to tackle obesity, it was reported. The trial ...

Research revealed that medications widely used for diabetes and obesity may offer significant benefits for patients with ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

It has been reported that pharmacies are "ready and able" to offer weight loss jabs on the NHS at a prescription price of ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

NHS to trial prescribing the appetite-supressing drugs after a short consultation at a high street pharmacy as Government ...

Obesity can lead to a chronic inflammatory state within the body. What drives this inflammation? Does inflammation, in turn, ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

Semaglutide — known by brand names Ozempic and Wegovy — works in the brain to impact satiety. Over the past two years, the ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...